Skip to main content
Top
Published in: American Journal of Clinical Dermatology 6/2008

01-12-2008 | Correspondence

Improvement in Psoriasis following Treatment with Gabapentin and Pregabalin

Authors: Steven T. Boyd, Linda Mihm, Nolton W. Causey

Published in: American Journal of Clinical Dermatology | Issue 6/2008

Login to get access

Excerpt

A 56-year-old White male with a history of psoriasis presented to a retail pharmacy stating that he had experienced improvement in his psoriasis since starting gabapentin and pregabalin for neuropathic pain. His medical history consisted of dyslipidemia, hypertension, panic attacks, neuropathic pain, and psoriasis. The patient had a family history of psoriasis, with both his father and brother having mild psoriasis covering <5% of their body. Based on the subjective data from the patient and limited objective documentation in his medical chart, the patient was classified as having mild-to-moderate psoriasis with guttate and erythrodermic lesions affecting at least 2–3% of his body surface. The main areas affected were his elbows, knees, back of the hands, face, legs, and buttocks. He had tried multiple topical treatments, including hydrocortisone and clobetasol, with only minimal benefits. The patient had never received systemic treatment for his psoriasis. …
Literature
1.
go back to reference Nijsten T, Margolis DJ, Feldman SR, et al. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol 2005 Mar; 52 (3 Pt 1): 434–44PubMedCrossRef Nijsten T, Margolis DJ, Feldman SR, et al. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol 2005 Mar; 52 (3 Pt 1): 434–44PubMedCrossRef
2.
go back to reference Stern RS, Nijsten T, Feldman SR, et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004 Mar; 9 (2): 136–9PubMedCrossRef Stern RS, Nijsten T, Feldman SR, et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004 Mar; 9 (2): 136–9PubMedCrossRef
Metadata
Title
Improvement in Psoriasis following Treatment with Gabapentin and Pregabalin
Authors
Steven T. Boyd
Linda Mihm
Nolton W. Causey
Publication date
01-12-2008
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 6/2008
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/0128071-200809060-00012

Other articles of this Issue 6/2008

American Journal of Clinical Dermatology 6/2008 Go to the issue

Book Review

Book Review

Acknowledgment

Acknowledgment